Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3622909

COc1ccc(C)cc1S(=O)(=O)N1CCc2c(CN3CCCC3)cccc21.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
PKM P14618 1/20 0.46
KMT2A Q03164 5/20 0.44
TSHR P16473 3/20 0.44
CPT1A P50416 3/20 0.43
CPT1B Q92523 3/20 0.43
CPT2 P23786 2/20 0.42
POLB P06746 2/20 0.42
HSD17B10 Q99714 1/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3617279 0.93 ALDH1A1 (0.47) ALDH1A1PKMKMT2ATSHRCPT1A
SCHEMBL3623663 0.92 TSHR (0.51) ALDH1A1PKMKMT2ATSHRCPT1A
Trifluoroacetic Acid SCHEMBL3626187 0.87 CPT1A (0.44) ALDH1A1PKMKMT2ATSHRCPT1A
SCHEMBL3626085 0.85 ALDH1A1 (0.52) ALDH1A1PKMKMT2ATSHRCPT1A
SCHEMBL3620704 0.79 ALDH1A1 (0.43) ALDH1A1PKMKMT2ATSHRCPT1A
SCHEMBL3626204 0.78 KMT2A (0.49) ALDH1A1PKMKMT2ATSHRCPT1A
Trifluoroacetic Acid SCHEMBL3618819 0.78 HTR6 (0.50) ALDH1A1PKMTSHRCPT1ACPT1B
SCHEMBL3623725 0.77 KMT2A (0.55) ALDH1A1PKMKMT2ATSHRPOLB
SCHEMBL3625987 0.73 KMT2A (0.52) ALDH1A1PKMKMT2ATSHRCPT1A
Trifluoroacetic Acid SCHEMBL3619410 0.73 HTR6 (0.59) ALDH1A1PKMCPT1ACPT1BCPT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046741-B1 INDOLES AS 5-HT6 MODULATORS PROXIMAGEN LTD (GB) 2012-10-31 EP disclosed
US-7812017-B2 4-substituted indole and indoline compounds BIOVITRUM AB (PUBL.) (SE) 2010-10-12 US disclosed
EP-2046741-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (publ) (SE) 2009-04-15 EP disclosed
US-20080032968-A1 New compounds PROXIMAGEN NEUROSCIENCE PLC (GB) 2008-02-07 US disclosed
WO-2008003703-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (PUBL) (SE) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080032968-A1 New compounds HTR6, HTR1B, HTR1A ALDH1A1 917/4885PKM 1474/4885KMT2A 3558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.